Private Wealth Partners
VRTX icon

Private Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$979K Hold
1,873
– – 0.07% 105
2026
Q2 		$930K Buy
1,873
+488
+35% +$216K 0.07% 107
2026
Q1 		$618K Buy
1,385
+150
+12% +$69.9K 0.05% 119
2025
Q4 		$560K Hold
1,235
– – 0.04% 123
2025
Q3 		$484K Sell
1,235
-250
-17% -$104K 0.03% 128
2025
Q2 		$661K Hold
1,485
– – 0.05% 115
2025
Q1 		$720K Sell
1,485
-10
-0.7% -$4.66K 0.06% 103
2024
Q4 		$602K Sell
1,495
-930
-38% -$431K 0.05% 119
2024
Q3 		$1.13M Buy
2,425
+925
+62% +$444K 0.09% 87
2024
Q2 		$703K Hold
1,500
– – 0.05% 100
2024
Q1 		$627K Sell
1,500
-1,890
-56% -$799K 0.05% 97
2023
Q4 		$1.38M Hold
3,390
– – 0.12% 74
2023
Q3 		$1.18M Sell
3,390
-50
-1% -$17.5K 0.11% 70
2023
Q2 		$1.21M Sell
3,440
-90
-3% -$30.3K 0.11% 69
2023
Q1 		$1.11M Buy
+3,530
New +$1.06M 0.11% 75
2021
Q3 		– Sell
-14,355
Closed -$2.89M – 84
2021
Q2 		$2.89M Sell
14,355
-458
-3% -$95.8K 0.27% 51
2021
Q1 		$3.18M Buy
14,813
+934
+7% +$205K 0.34% 47
2020
Q4 		$3.28M Buy
13,879
+2,459
+22% +$564K 0.36% 47
2020
Q3 		$3.11M Buy
11,420
+776
+7% +$214K 0.36% 43
2020
Q2 		$3.09M Buy
10,644
+405
+4% +$110K 0.42% 46
2020
Q1 		$2.44M Buy
+10,239
New +$2.35M 0.41% 44
2014
Q4 		– Sell
-2,000
Closed -$225K – 172
2014
Q3 		$225K Buy
+2,000
New +$190K 0.05% 154

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Private Wealth Partners's VRTX Position: Q3 2026 in Review

Private Wealth Partners held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 1,873 shares worth $979K. The position accounts for 0.07% of the portfolio, ranked #105.

Private Wealth Partners first reported a position in VRTX in Q3 2014 and has held it in 22 quarters since. The position peaked at $3.28M in Q4 2020. 438 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Private Wealth Partners held 1,873 shares of Vertex Pharmaceuticals worth $979K as of Q3 2026.
  • Private Wealth Partners left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.07% of Private Wealth Partners's portfolio in Q3 2026, its #105 holding.
  • Private Wealth Partners first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 22 quarters since.
  • Private Wealth Partners's Vertex Pharmaceuticals position peaked at $3.28M in Q4 2020.
  • 438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Private Wealth Partners's 13F filing for Q3 2026, filed 22 Oct 2026.